Table of Contents
Editorials
| Current status and prospects of multimodality therapy of lung cancer | |
| Yilong WU | 241-242 |
Multimodality Therapy of Lung Cancer
| Induction treatment of locally advanced non-small cell lung cancer | |
| Guoliang JIANG | 243-246 |
| Application of chemotherapy in multimodality therapy of lung cancer | |
| Meilin LIAO | 247-250 |
| A randomized clinical trial of preoperative neoadjuvant chemotherapy followed by surgery in the treatment of stage III non-small cell lung cancer | |
| Qinghua ZHOU, Lunxu LIU, Lu LI, Guowei CHE, Junjie YANG, Yongfan ZHAO, Jun CHEN, Yun WANG, Jianjun QIN, Mei HOU, Youlin GONG, Wusheng LU, Zhiping LI | 251-256 |
| Application of thoracoscope on the diagnosis and multimodality therapy of lung cancer | |
| Lijia GU, Yilong WU | 257-262 |
| Significance of radical dissection of mediastinal lymphonde in surgical treatment of lung cancer | |
| Siyu WANG, Yilong WU | 263-267 |
| A random study on taxol and concomitant radiotherapy vs sequential combined modality in treatment of advanced non-small cell lung cancer | |
| Xiaochun ZHANG, Fanying LIU, Fengsheng QU, Shiqiang HONG, Hongjing SHEN, Gongli XU | 268-271 |
| Bronchial arterial infusion chemotherapy in the treatment of stage III non-small cell lung cancer | |
| Qiang LI, Ping TAO, Yongtao HAN, Lin PENG, Jiang ZHU, Feng XU, Gengli WANG, Guohui XU | 272-274 |
Pen Conversations
| Review and comments on the 1999 WHO/IASLC histological classification of lung cancer | |
| Zuoxuan XIE | 275-280 |
Basic Research
| A study on the characteristics of the membrane potassium channels in human non-small cell lung cancer cell | |
| Tianyang DAI, Qinghua ZHOU, Xiaorong ZENG, Jun HE, Yan YANG, Chengwen LI, Delian REN, Lunxu LIU, Bin LIAO | 281-286 |
| Role of cyclin D1 protein, p53 protein and DNA ploidy in judging malignancy and prognosis of lung cancer | |
| Cuimin DING, Jinsheng XIU, Lianfu ZUO, Jianghui LIU, Jianwen GUO | 287-289 |
| Levels of sexual hormones in plasma of male patients with lung cancer and their clinical significance | |
| Xiangdong ZHOU, Hongwei CAO, Wenqin CAI | 290-292 |
Clinical Research
| An initial study on DSA features of pulmonary hypoperfusion second to cancerous invasion of central pulmonary artery in lung cancer | |
| Wusheng LU, Dajing GUO, Jingtao MIAO, Chang LIU, Shuyu HU, Wenxiu LIU, He JIAO | 293-295 |
| The phase Ⅱ clinical trial of Seratia Marcescens Anticancer Vaccine (S311) for malignant pleural effusions | |
| Yunzhong ZHU, Heling SHI, Hao QIAN, Wenxia HUANG, Zhuan HONG, Yiping ZHANG, Nong XU, Li ZHANG, Donggeng LIU, Zhongsheng TONG, Shufen LI, Lijian ZHANG, Wen ZHENG | 296-298 |
Evidence-Based Medicine on Lung Cancer
| Expression of human telomerase in lung cancer：A meta-analysis of diagnostic test | |
| Jin LIU, Qing YANG, Yajia LAN, Mianzhen WANG | 299-302 |
Clinical Experience
| 179例N2期非小细胞肺癌外科治疗体会 | |
| 曲 家骐, 侯 维平, 高 昕, 滕 洪, 童 向东, 于 修义 | 303-304 |
| 心律失常与肺癌手术的关系及防治 | |
| 陈 思伟, 吴 伟东 | 305-306 |
| 99mTc-MDP肺癌骨显像的骨外放射性聚集影临床分析 | |
| 洪 巧银, 肖 必文 | 307-308 |
| CT导引钝头钩型胸膜活检针经皮肺内周围性肿块活检的诊断价值 | |
| 刘 宪文, 任 泽凤 | 309-310 |
| 直肠癌肺转移的外科治疗和预后 | |
| 李 印, 许 金良, 邵 龄芳, 马 军, 谢 博雄 | 311-312 |
| 肺癌患者继发肺部感染的痰菌及药敏分析 | |
| 王 红梅, 廖 国清, 雷 红, 刘 鹏辉, 戴 海峰, 解 国清, 邹 建军 | 313 |
Minireview
| 小细胞肺癌的离子通道研究 | |
| 王 立平, 邵 国光 | 314-317 |
| 血管内皮生长因子及其与肺癌关系的研究进展 | |
| 马 莹, 王 新允 | 318-320 |
Short Communications
| HCPT联合CAP方案治疗非小细胞肺癌22例 | |
| 姜 培娣, 谷 祖涛, 李 海青 | 246 |
| 36例以肺外表现为首发症状肺癌的分析 | |
| 陈 传波 | 312 |
Case Reports
| 威猛致过敏性紫癜一例报告 | |
| 巫 云立 | 271 |
| 干扰素α 2a致阵发性室上性心动过速一例报告 | |
| 康 宁, 李 艳琴 | 302 |
